The Potassium Supplementation Study
This study will test whether potassium supplementation can reduce the deleterious effect of a high sodium diet on blood vessel function, blood pressure reactivity and autonomic nervous system function in apparently healthy adults.
Conditions:
🦠 Cardiovascular Health 🦠 Cardiovascular Risk Factor
🗓️ Study Start (Actual) 24 January 2022
🗓️ Primary Completion (Estimated) 31 January 2025
✅ Study Completion (Estimated) 30 June 2025
👥 Enrollment (Estimated) 30
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Newark, Delaware, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * men and women
    • * 18-45 years of age
    • * all races/ethnicities
    • * BMI \< 30 kg/m2
    • * BP \< 130/80 mmHg

    Exclusion Criteria:

    • * presence of hypertension
    • * known heart disease
    • * diabetes
    • * kidney disease
    • * cancer
    • * inflammatory conditions
    • * blood clotting disorders
    • * pregnancy
    • * adrenal gland disorder
    • * history of stomach or intestinal bleeding
    • * history of kidney stones
    • * serum potassium outside of the normal range
Ages Eligible for Study: 18 Years to 45 Years (ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 29 March 2022
  • First Submitted that Met QC Criteria 30 May 2023
  • First Posted 5 June 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 30 May 2023
  • Last Update Posted 5 June 2023
  • Last Verified May 2023